Found 16 matching trials
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder PHASE3 This will be an open-label uncontrolled trial to evaluate the safety and to...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole PHASE3 The purpose of this study is to compare retrospective hospitalization rates...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia PHASE3 The primary objective of this study was to continue to provide aripiprazole...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia PHASE3 The phase 3 Trial 31-12-291 is part of the aripiprazole IM depot clinical d...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder PHASE1 The purpose of this trial is to determine the safety and tolerability of mu...
Show More Location
Woodland International Research Group
Learn More & Join Trial
An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia PHASE1 The purpose of this study is to determine whether aripiprazole injection in...
Show More Location
Comprehensive Clinical Development, Inc.
Learn More & Join Trial
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients PHASE3 This will be a randomized, double-blind, placebo-controlled trial to assess...
Show More Location
Multiple Locations
Learn More & Join Trial
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia PHASE3 The purpose of the trial was to evaluate the efficacy, safety, and tolerabi...
Show More Location
Otsuka Investigational Site
Learn More & Join Trial
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia PHASE3 The purpose of the this trial is to evaluate the efficacy, safety, and tole...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia PHASE3 The primary purpose of this study is to evaluate the overall efficacy of ar...
Show More Location
Multiple Locations
Learn More & Join Trial